Cite
Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.
MLA
Hartman, Linda, et al. “Favourable Effect of a ‘Second Hit’ after 13 Weeks in Early RA Non-Responders: The Amsterdam COBRA Treat-to-Target Randomized Trial.” Rheumatology, vol. 62, no. 6, June 2023, pp. 2098–105. EBSCOhost, https://doi.org/10.1093/rheumatology/keac582.
APA
Hartman, L., Rasch, L. A., Turk, S. A., Wee, M. M. ter, Kerstens, P. J. S. M., Laken, C. J. van der, Nurmohamed, M. T., Schaardenburg, D. van, Tuyl, L. H. D. van, Voskuyl, A. E., Boers, M., & Lems, W. F. (2023). Favourable effect of a “second hit” after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial. Rheumatology, 62(6), 2098–2105. https://doi.org/10.1093/rheumatology/keac582
Chicago
Hartman, Linda, Linda A Rasch, Samina A Turk, Marieke M ter Wee, Pit J S M Kerstens, Conny J van der Laken, Michael T Nurmohamed, et al. 2023. “Favourable Effect of a ‘Second Hit’ after 13 Weeks in Early RA Non-Responders: The Amsterdam COBRA Treat-to-Target Randomized Trial.” Rheumatology 62 (6): 2098–2105. doi:10.1093/rheumatology/keac582.